HK1213809A1 - 用於治療肥胖症的藥物組合物 - Google Patents

用於治療肥胖症的藥物組合物

Info

Publication number
HK1213809A1
HK1213809A1 HK16101901.8A HK16101901A HK1213809A1 HK 1213809 A1 HK1213809 A1 HK 1213809A1 HK 16101901 A HK16101901 A HK 16101901A HK 1213809 A1 HK1213809 A1 HK 1213809A1
Authority
HK
Hong Kong
Prior art keywords
pharmaceutical compositions
treating obesity
obesity
treating
pharmaceutical
Prior art date
Application number
HK16101901.8A
Other languages
English (en)
Inventor
Bernard Bizzini
Original Assignee
Diopeite Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diopeite Sa filed Critical Diopeite Sa
Publication of HK1213809A1 publication Critical patent/HK1213809A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
HK16101901.8A 2012-12-03 2016-02-19 用於治療肥胖症的藥物組合物 HK1213809A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000268A ITFI20120268A1 (it) 2012-12-03 2012-12-03 Composizioni farmaceutiche per il trattamento dell'obesita'
PCT/IB2013/060558 WO2014087317A1 (en) 2012-12-03 2013-12-02 Pharmaceutical compositions for treating obesity

Publications (1)

Publication Number Publication Date
HK1213809A1 true HK1213809A1 (zh) 2016-07-15

Family

ID=47603928

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16101901.8A HK1213809A1 (zh) 2012-12-03 2016-02-19 用於治療肥胖症的藥物組合物

Country Status (11)

Country Link
US (1) US20150306129A1 (zh)
EP (1) EP2925330B1 (zh)
JP (1) JP2016502535A (zh)
KR (1) KR20150092746A (zh)
CN (1) CN104902908A (zh)
AU (1) AU2013353651A1 (zh)
CA (1) CA2893541A1 (zh)
HK (1) HK1213809A1 (zh)
IT (1) ITFI20120268A1 (zh)
RU (1) RU2015126549A (zh)
WO (1) WO2014087317A1 (zh)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3023104A (en) 1960-07-05 1962-02-27 American Viscose Corp Food compositions incorporating cellulose crystallite aggregates
JPS55165532A (en) 1979-06-12 1980-12-24 Tokyo Shibaura Electric Co Vacuum switch
DD148342A1 (de) * 1980-01-07 1981-05-20 Horst Dautzenberg Verfahren zur herstellung von carboxymethylcellulose mit erhoehter loesungsviskositaet
DE69232126T3 (de) 1991-03-01 2008-07-17 The Dow Chemical Co., Midland Aufnehmbare Zubereitungen enthaltend wasserlösliche, hochviskose Cellulosether
US5721221A (en) * 1991-03-08 1998-02-24 Regents Of The University Of Minnesota Lowering blood cholesterol levels using water soluble cellulose ethers
IT1267498B1 (it) 1994-11-10 1997-02-05 P & G Spa Derivato cellulosico cationico, relativo uso per la riduzione dei livelli di colesterolo e relativa composizione farmaceutica.
WO2003103640A1 (en) * 2002-06-10 2003-12-18 Elan Pharma International, Ltd Nanoparticulate formulations comprising hmg coa reductase inhibitor derivatives (“statins”), novel combinations thereof as well as manufacturing of these pharmaceutical compositions
DE10339354A1 (de) * 2003-08-27 2005-04-07 Beisel, Günther Mittel zur Behandlung des metabolischen Syndroms
CN1651465A (zh) * 2004-02-04 2005-08-10 陈建操 糖基修饰改性膳食纤维及其制备方法和应用
US8883193B2 (en) * 2005-06-29 2014-11-11 The University Of Alabama Cellulosic biocomposites as molecular scaffolds for nano-architectures
WO2007036920A2 (en) * 2005-09-28 2007-04-05 Alltracel Development Services Limited Therapeutic use of polyanhydroglucronic acid
US20100291238A1 (en) * 2008-07-21 2010-11-18 Michael Cherkassky Appetite suppressant product and method

Also Published As

Publication number Publication date
US20150306129A1 (en) 2015-10-29
ITFI20120268A1 (it) 2014-06-04
KR20150092746A (ko) 2015-08-13
RU2015126549A (ru) 2017-01-10
EP2925330B1 (en) 2021-04-21
CN104902908A (zh) 2015-09-09
CA2893541A1 (en) 2014-06-12
EP2925330A1 (en) 2015-10-07
WO2014087317A1 (en) 2014-06-12
AU2013353651A1 (en) 2015-06-11
JP2016502535A (ja) 2016-01-28

Similar Documents

Publication Publication Date Title
HK1206297A1 (zh) 用於聯合療法的藥物組合物
HK1209638A1 (zh) 藥物組合物
GB201113662D0 (en) Pharmaceutical compositions
ZA201308208B (en) Pharmaceutical compositions
ZA201501930B (en) Pharmaceutical composition
HK1199824A1 (zh) 藥物組合物
HRP20190050T1 (hr) Farmaceutski pripravci za kombinacijsku terapiju
EP2832730A4 (en) MIRABEGRAPHIC PHARMACEUTICAL COMPOSITION
EP2897613A4 (en) TREATMENT COMPOSITIONS
PL3524260T3 (pl) Kompozycje farmaceutyczne do leczenia braku apetytu
EP2823825A4 (en) PHARMACEUTICAL COMPOSITION FOR TREATING CANCER
SG11201500211PA (en) Composition for preventing or treating osteoarthritis
GB201118181D0 (en) Pharmaceutical compositions
IL217807A0 (en) Therapeutic compositions
EP2926817A4 (en) STABLE PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF OSTEOPOROSIS
ZA201502987B (en) Pharmaceutical composition
EP2897590A4 (en) PHARMACEUTICAL COMPOSITION
GB201211153D0 (en) Pharmaceutical compositions
PL2663318T3 (pl) Kompozycja farmaceutyczna do leczenia raka
HK1213809A1 (zh) 用於治療肥胖症的藥物組合物
EP2851078A4 (en) PHARMACEUTICAL COMPOSITION
EP2785343A4 (en) PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING HYPERLIPIDEMIA
EP2714715A4 (en) PHARMACEUTICAL COMPOSITIONS
IL238075A0 (en) pharmaceutical preparations
HUE043019T2 (hu) Gyógyszerészeti készítmények kombinációs terápia céljára